In Qingdao, a beautiful coastal city, witnessed a grand meeting as the CMEF (the largest medical trade fair in the Asia-Pacific region, covering a comprehensive industrial service chain covering the entire industrial chain of medical devices, integrating product technology, service innovation and trade, academic exchange, and education) kicked off on October 19-22. As many as 3,000 companies in the field of medical devices from over 20 countries, including South Korea, Cambodia, Russia, Thailand, Indonesia and China, attended the great 4-day event.Under the theme of “Intelligence Reshapes the Future”, the meeting brought together experts, distributors and manufacturers from across the world to exchange experience and showcase the innovation.
At booth S3G15, one of star products from Wondfo- Finecare Series, provides reliable and quantitative results of various kinds of analytes in human blood or urine within several minutes. FinecareII Plus has the extra quick operating mode for large number of specimens, FinecareIII Plus, the updated version of Finecare II Plus, is able to test 20 channels at one time. Finecare Series can test 40 items including Metabolic Markers, Thyroid Function, Inflammation Markers, Coagulation, Tumor Markers, Diabetic＆Renal Injury Markers, Fertility, Cardiac Markers and Cortisol etc.
Another star product – Dry Chemistry Analyzer DC-101, attracted great attention from the audience. Equipped with dry chemistry technology, Dry Chemistry Analyzer DC-101 supports serum, plasma, whole blood and urine testing. Dry Chemistry Analyzer DC-101 features short TAT with only 1-5 minutes to get the results, quantitative measurement with reflective photometry for accurate testing, less sample volume with only 7-20 μl and user friendly without washing.
Besides, it also should be highlighted that Optical Coagulation Analyzer OCG-102 won the applause from the audience. Wondfo’s Optical Coagulation Analyzer OCG-102 is convenient and portable with its dried-reagent test strips stored at room temperature and 850g of the weight. The results of 5 items (PT/APTT/ACT/FIB) , which belong to domestic initiation, will be released within 1 to 5 minutes.
It is obvious that CMEF is a significant platform for Wondfo to showcase its achievements and vision for the future of medical care. Wondfo’s participation in CMEF underscores the company’s increasing global presence and its commitment to the healthcare.